IB Acquisition Corp.
Status: Live Deal
U=S+R
R=S/20
| IPO Proceeds, $M | $115.00M |
|---|---|
| IPO Date | Mar 26, 2024 |
| CEO | Adelmo “Al” Lopez |
| Left Lead | I-Bankers Securities |
| IPO Cash in Trust | 100.5% |
| SPAC Tenor | 18 + 6 |
| IPO Sector | General ▶ |
| IPO Geography | Global |
| Target Company | GNQ Insilico |
| Deal Announced | Mar 16, 2026 |
| Deal Size, $M | $568.50M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | TBD |
| Amendment Vote | Mar 25, 2026 |
IBAC
IBACU
IBACR
| Price | $10.70 |
|---|---|
| Last closing price | $10.74 |
| H/L, today | $10.70 / $10.72 |
| Volume, today | 24,291 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.